The "3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035" report has been added to Research and Markets' offering.
This report features:
- A detailed overview of the current market landscape of 3D bioprinters and 3D bioprinted products, highlighting the contributions of industry and non-industry players, including information on the various technological aspects and key specifications of such technologies / products.
- Profiles of developers of bioprinting devices / technologies and bioprinted products. Each profile includes an overview of the company, information on their financials (wherever available), details on their respective product portfolios, 3D bioprinting specific collaborations, and an informed future outlook.
- A comprehensive product competitiveness analysis of existing 3D bioprinters, based on supplier power and product specific features such as type of technology and range of applications.
- An analysis of the partnerships that have been established in the recent past, covering research agreements, distribution agreements, product development agreements and other relevant deals, along with information on the collaborators / partners.
- An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings received by companies that are focused in this area.
- An analysis depicting the prevalent and emerging trends in 3D bioprinting as observed on the social media platform, Twitter. The report also includes a detailed case study on the upcoming trends, such as use of stem cells as bioinks, emergence of the concept of 4D bioprinting and commercialization of low-cost bioprinters, based on inputs from primary and secondary research.
- An analysis of intellectual property portfolio related to 3D bioprinting. The study presents a high-level view on the granted patents and submitted patent applications related to these technologies, highlighting the prevalent trends in this domain. In addition, the analysis highlights the most active geographies and the key players driving innovation in this field.
The 3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035' report provides a comprehensive study on the current market landscape of the 3D bioprinting industry, featuring an elaborate discussion on the future potential of this evolving market. The field has seen the emergence of many new players in the past few years; in fact, several well-known players of the 3D printing industry have broadened their focus to launch new initiatives specific to 3D bioprinting.
3D printing has garnered significant attention within the healthcare industry. The concept of 3D bioprinting was conceived in the late 1990s; since then, various industry stakeholders and academicians have undertaken several initiatives in order to further develop / improve this technology for a variety of applications. Organovo was the first company to enter the 3D bioprinting space by printing functional blood vessels in 2010. The company now offers 3D printed kidney and liver tissue models. There have been a number of other notable attempts to create fully functional 3D bioprinted tissues.
The current applications of 3D bioprinted products cater to various requirements within the pharmaceutical industry for clinical testing of therapeutic drugs. Owing to the evident interspecies differences, drug candidates that are shown to be efficacious in animal models often fail in humans. For such purposes, 3D bioprinting can be used to develop more accurate, human specific disease models. Further, there is a severe unmet need when it comes to organ transplants. Therefore, the ability to synthetically create organs for transplantation purposes is expected to generate a lot of interest amongst pharmaceutical / biotechnology players in the coming years.
The current market landscape of 3D bioprinting is characterized by the presence of nearly equal number of industry and non-industry players, featuring a number of startups and university spin-offs. Although there are several 3D bioprinting technologies already available, active efforts are being made to add to the intellectual property portfolio. The field has witnessed growing partnering activity and has also managed to capture the interest of both public and private sector investors.Despite certain challenges, several technical advancements and high unmet need of current patients waiting for organ transplants is anticipated to significantly drive future growth.
Key Topics Covered:
1. Preface
- Scope of the Report
- Research Methodology
- Chapter Outlines
2. Executive Summary
3. Introduction
- 3D Printing Technology
- 3D Bioprinting: Printing of Living Cells, Tissues and Organs
4. Market Landscape
- 3D Bioprinting: Overall Market Landscape
- 3D Bioprinters by Non-Industry Players
- 3D Bioprinted Products by Non-Industry Players
5. Company Profiles
- 3Dynamic Systems
- Aspect Biosystems
- Allevi (formerly BioBots)
- BioDan Group
- CELLINK
- EnvisionTEC
- GeSiM
- MEDPRIN BIOTECH
- microdrop Technologies
- MicroFab Technologies
- Nano3D Biosciences
- Organovo
- Qingdao Unique Products Develop
- regenHU
- SunP Biotech International
6. Recent Collaborations and Funding
- Partnership Models
- 3D Bioprinting: Recent Collaborations
- Venture Capital Interest
- Types of Funding
- 3D Bioprinting: Funding Instances
7. SWOT Analysis
8. Emerging Trends on Social Media
- Trends on Twitter
- Popular Keywords and Word Cloud Analysis
9. Recent Trends in 3D Bioprinting Industry
- Introduction of Scaffold-Free Bioprinting
- Emergence of 4D Bioprinting: the Next Generation of 3D Bioprinting
- Use of Stem Cells as Bio Ink
- Development of UV 3D Bioprinting, a Modified Stereolithography Approach
- Establishment of Spin-Offs of Academic Institutes
- Entry of Well-Established Players of 3D Printing Industry in Bioprinting Industry
- Introduction of Low-Priced Bioprinters
- Increasing Number of Initiatives Taken by Governments of Different Countries
10. Product Competitiveness Analysis
- 3D Bioprinters: 2 x 2 Product Competitiveness vs. Supplier Power Analysis
11. Patent Analysis
- 3D Bioprinting Patents: Distribution by Publication Year
- 3D Bioprinting Patents: Distribution by Geographical Location
- 3D Bioprinting Patents: Distribution by CPC Classifications
- 3D Bioprinting Patents: Emerging Areas
- 3D Bioprinting Patents: Leading Players
12. Market Forecast and Opportunity Analysis
- Forecast Methodology
- Overall 3D Bioprinting Market, 2018-2035
- 3D Bioprinting Market: Distribution by Applications
- 3D Bioprinting Market: Distribution by Region (North America, Europe, Asia Pacific and Rest of the World)
- 3D Bioprinting Market: Distribution by Technology (Extrusion, Inkjet, Laser and Others)
13. Conclusion
- 3D Bioprinting has Garnered Significant Attention within the Biopharmaceutical Industry
- The Competitive Market Landscape Features a Mix of Industry and Non-Industry Players
- North America and Europe Dominate the Current Market; Several Companies based in the Asia Pacific are also Making Notable Progress
- Research Continues to be the Major Focus as Stakeholders Strive to Improve Existing Methods and Technologies
- Increasing Partnership Activity and Financial Support from Public and Private Investors are Expected to Drive Growth
- Recent Advances are Expected to Act as Catalyst to the Success of 3D Bioprinting
- Inherent Challenges Must be Overcome to Tap the Multi-billion Dollar Opportunity in the Long Term
14. Interview Transcripts
- Douglas Chrisey, Professor, Tulane University
- Igor Zlatkin, Application Scientist and Chirantan Kanani, Technology & Product Development, Digilab
- Fanny Geraldo and Lisa Oliver, Researchers, University of Nantes
- Glauco R Souza, President & Chief Scientific Officer and Hubert Tseng, Senior Research Scientist, n3D Biosciences
- Kenneth Church , President & Chief Executive Officer and Xudong Chen , Executive Vice President Business Development & Sales, nScrypt
- Laura Bosworth , Chief Executive Officer & Co-Founder, TeVido BioDevices
- Lauralyn McDaniel , Industrial Manager, SME
- Marc Thurner , Chief Executive Officer, regenHU
- Roger Narayan , Professor, North Carolina State University
- Simon Fried , Chief Business Officer, Nano Dimension
- Anonymous, MicroFab Technologies
